Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

Ann Intern Med. 2001 Dec 4;135(11):954-64.

PMID:
11730396
2.

Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.

Kilby JM, Goepfert PA, Miller AP, Gnann JW Jr, Sillers M, Saag MS, Bucy RP.

Ann Intern Med. 2000 Sep 19;133(6):435-8. Review.

PMID:
10975961
3.

Indinavir: a review of its use in the management of HIV infection.

Plosker GL, Noble S.

Drugs. 1999 Dec;58(6):1165-203. Review.

PMID:
10651394
6.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Sangani PR, Kennedy GE.

Cochrane Database Syst Rev. 2003;(4):CD002037. Review.

PMID:
14583945
7.

Measuring viral load in the clinical setting.

Harrigan R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S34-40. Review.

PMID:
8595506
8.

The value of the CD4+ count of 500 cells/microliters.

Volberding P.

Drugs. 1995;49 Suppl 1:4-8; discussion 38-40. Review.

PMID:
7614901
9.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Feldman KA, Kennedy GE.

Cochrane Database Syst Rev. 2000;(2):CD002037. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD002037.

PMID:
10796850
10.

The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs.

Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA.

AIDS. 1999 May 7;13(7):797-804. Review.

PMID:
10357378
11.

Immunomodulatory effects of antiretroviral chemotherapy.

Schooley RT.

J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):110-3. Review.

PMID:
8782019
12.

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

Viani RM, Dankner WM, Muelenaer PA, Spector SA.

Pediatrics. 1999 Dec;104(6):1394-6. Review.

PMID:
10585995
13.

Advances in antiretroviral therapy and viral load monitoring.

Hammer SM.

AIDS. 1996 Dec;10 Suppl 3:S1-11. Review.

PMID:
8970706
14.

Use of virologic markers in clinical practice.

Saag MS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S3-13. Review.

PMID:
9389310
16.

Plasma viral load testing in the management of HIV infection.

Mylonakis E, Paliou M, Rich JD.

Am Fam Physician. 2001 Feb 1;63(3):483-90, 495-6. Review.

18.

Zidovudine (Retrovir) update.

Rachlis AR.

CMAJ. 1990 Dec 1;143(11):1177-85. Review.

19.

Natural history of HIV-1 infection.

Vergis EN, Mellors JW.

Infect Dis Clin North Am. 2000 Dec;14(4):809-25, v-vi. Review.

PMID:
11144640
20.

Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1.

Johnson VA.

J Infect Dis. 1995 Mar;171 Suppl 2:S140-9. Review.

PMID:
7861019

Supplemental Content

Support Center